TY  - JOUR 
AU  - Flores Montero, Juan Alejandro
AU  - Sanoja Flores, Luzalba
AU  - Paiva, Bruno
AU  - Puig Morón, Noemí
AU  - García Sánchez, Omar
AU  - Böttcher, Sebastian
AU  - van der Velden, VHJ
AU  - Pérez Morán, José
AU  - Vidriales Vicente, María Belén
AU  - García Sanz, Ramón
AU  - Jiménez, C.
AU  - González Díaz, Marcos
AU  - Martínez-López, J.
AU  - Corral-Mateos, A.
AU  - Grigori, G.E.
AU  - Fluxá, R.
AU  - Pontes, R.
AU  - Caetano, J.
AU  - Sedek, L.
AU  - Cañizo Fernández-Roldán, María Consuelo del
AU  - Bladé, Joan
AU  - Huerta, Juan José la
AU  - Aguilar, Carlos
AU  - Bárez, Abelardo
AU  - García-Mateo, A.
AU  - Labrador Gómez, Jorge
AU  - Leoz, P.
AU  - Aguilera-Sanz, C.
AU  - San Miguel, Jesús F
AU  - Mateos Manteca, María Victoria
AU  - Durie, Brian
AU  - van Dongen, J.J.M.
AU  - Orfao de Matos Correia e Vale, José Alberto
PY  - 2017
UR  - http://hdl.handle.net/10366/136897
AB  - [EN]Flow cytometry has become a highly valuable method to monitor minimal residual disease (MRD) and evaluate the depth of complete response (CR) in bone marrow (BM) of multiple myeloma (MM) after therapy. However, current flow-MRD has lower...
LA  - eng
KW  - Oncology
KW  - Next generation flow
KW  - Multiple myeloma
KW  - Minimal residual disease
TI  - Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
DO  - 10.1038/leu.2017.29
ER  -